Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2021-01-30
2021-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
NCT04581148
Host RNA Profiles to Detect Infections in Young Infants
NCT04823026
SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19
NCT04979871
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
NCT04528251
The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
NCT01081379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children with a documented positive COVID-19 nasal smear real-time reverse-transcriptase polymerase chain reaction (PCR) assay were included.
Exclusion Criteria
1 Month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mersin University
OTHER
Dicle University
OTHER
Bezmialem Vakif University
OTHER
Uludag University
OTHER
Mersin Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Özdemir
Assoc Prof Ali Özdemir
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali̇ Özdemi̇r, MD
Role: PRINCIPAL_INVESTIGATOR
Mersi̇n Şehi̇r Eği̇ti̇m Ve Araşti̇rma Hastanesi̇
Ali̇ Özdemi̇r
Role: PRINCIPAL_INVESTIGATOR
Mersi̇n Şehi̇r Eği̇ti̇m Ve Araşti̇rma Hastanesi̇
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mersin City Training & Research Hospital
Mersi̇n, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MersinTRH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.